Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Key issues in non-viral gene delivery.

C W Pouton1, L W Seymour

  • 1Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK. c.w.pouton@bath.ac.uk

Advanced Drug Delivery Reviews
|March 22, 2001
PubMed
Summary

Advancing non-viral gene therapy requires understanding delivery barriers. Future strategies may mimic viral attributes for improved polynucleotide delivery and efficiency in clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterising the developmental profile of human embryonic stem cell-derived medium spiny neuron progenitors and assessing mature neuron function using a CRISPR-generated human DARPP-32<sup>WT/eGFP-AMP</sup> reporter line.

Neurochemistry international·2017
Same author

Nanotherapeutics shielded with a pH responsive polymeric layer.

Physiological research·2015
Same author

Comparing mouse and human pluripotent stem cell derived cardiac cells: Both systems have advantages for pharmacological and toxicological screening.

Journal of pharmacological and toxicological methods·2015
Same author

Combining virotherapy and angiotherapy for the treatment of breast cancer.

Cancer gene therapy·2013
Same author

Midbrain and forebrain patterning delivers immunocytochemically and functionally similar populations of neuropeptide Y containing GABAergic neurons.

Neurochemistry international·2011
Same author

Endothelin-1 and angiotensin II modulate rate and contraction amplitude in a subpopulation of mouse embryonic stem cell-derived cardiomyocyte-containing bodies.

Stem cell research·2010

Area of Science:

  • Gene Therapy
  • Nanotechnology
  • Molecular Biology

Background:

  • Non-viral gene therapy faces significant challenges in delivering polynucleotides effectively.
  • Understanding barriers is crucial for developing successful gene delivery systems.
  • Current strategies need improvement for clinical application.

Purpose of the Study:

  • To review current knowledge on gene delivery systems' biodistribution and cellular interactions.
  • To identify key barriers hindering non-viral gene therapy efficacy.
  • To explore future directions for enhancing gene delivery efficiency.

Main Methods:

  • Literature review of existing research on gene delivery barriers.
  • Analysis of physicomechanical, physicochemical, and biological challenges.
  • Exploration of viral attributes for potential application in non-viral systems.

Main Results:

  • Physicomechanical, physicochemical, and biological barriers impede polynucleotide delivery.
  • Realistic strategies are needed for early-stage clinical trials.
  • Viral mechanisms offer insights for improving delivery efficiency.

Conclusions:

  • Overcoming delivery barriers is essential for the future of non-viral gene therapy.
  • Learning from viral evolution can lead to more effective gene delivery systems.
  • Developing stable, virus-like particles requires advanced control in assembly.

Related Experiment Videos